SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, whose advanced electroporation system is being tested worldwide for its ability to increase the effectiveness of DNA drugs and vaccines, has entered into an agreement with two distinguished research organizations to test a promising HIV vaccine, ADVAX, in human volunteers. Under the agreement, the Aaron Diamond AIDS Research Center (ADARC) will evaluate the ability of Ichor’s TriGrid Delivery System (TriGrid) to increase the immunogenicity of the vaccine. And the International AIDS Vaccine Initiative (IAVI) will provide the DNA vaccine, which has already been tested in humans using conventional delivery methods, and provide selected monitoring and data management support. The ADVAX vaccine was developed by IAVI and ADARC.
